Readout calendar · biotech and investor view
Upcoming women's health trial readouts
29 industry-sponsored trials in the conditions TrialsForHer tracks have a primary completion date between October 2026 and October 2027, according to ClinicalTrials.gov.
These are registry-reported dates, mostly estimates. Primary completion is when the last participant is examined for the main outcome. It is not a results announcement date, and sponsors often move it. 29 of the 29 dates below are marked "estimated" by the sponsor. Check the registry record before relying on any date.
| Primary completion | ID | Title | Lead sponsor | Condition | Phase | Enrolment |
|---|---|---|---|---|---|---|
| Q4 2026 | ||||||
| 27 Oct 2026 estimated | NCT07764328 | This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms. | Mila Mend Inc. | PCOS | N/A (non-drug) | 225 |
| Nov 2026 estimated | NCT07342400 | A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages | Galderma R&D | Menopause | N/A (non-drug) | 40 |
| Nov 2026 estimated | NCT07653620 | Hydration & Female Life Stages | PepsiCo Global R&D | Menopause | N/A (non-drug) | 72 |
| Dec 2026 estimated | NCT05643131 | Hyivy Device as Non-hormonal Therapy in Endometriosis | Hyivy Health Inc | Endometriosis | N/A (non-drug) | 20 |
| 1 Dec 2026 estimated | NCT05756023 | IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome | Egymedicalpedia | PCOS | N/A (non-drug) | 156 |
| Dec 2026 estimated | NCT06392997 | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology | ZIWIG | Endometriosis | Observational | 2,500 |
| Dec 2026 estimated | NCT06962345 | Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs. | Mucosa Innovations, S.L. | Menopause | N/A (non-drug) | 80 |
| Dec 2026 estimated | NCT07611305 | ProGo Menopause Wellbeing Study | Hofseth Biocare ASA | Menopause | N/A (non-drug) | 100 |
| 1 Dec 2026 estimated | NCT07861295 | Satavari and Ashoka for Menopause (SAM) Study | Vidya USA Corporation | Menopause | N/A (non-drug) | 50 |
| 11 Dec 2026 estimated | NCT07413705 | BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women | BTL Industries Ltd. | Menopause | N/A (non-drug) | 60 |
| Q1 2027 | ||||||
| Jan 2027 estimated | NCT06024109 | Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy | Aesculap AG | Endometriosis | Observational | 132 |
| Jan 2027 estimated | NCT07538167 | Food Trial Evaluating Fecal Abundance of SBD111 With Once-Daily Versus Twice-Daily Administration in Healthy Adults | Solarea Bio, Inc | Menopause | N/A (non-drug) | 80 |
| 1 Jan 2027 estimated | NCT07679074 | CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life | Samphire Group, Inc. | Endometriosis, Menopause | Observational | 50 |
| Jan 2027 estimated | NCT07880041 | Evaluation of the Effect of a Nutraceutical Supplement on Hair Growth and Hair Quality in Premenopausal and Menopausal Women | LycoRed Ltd. | Menopause | N/A (non-drug) | 60 |
| Feb 2027 estimated | NCT07118891 | Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause | AbCellera Biologics Inc. | Menopause | Phase 1/2 | 136 |
| 22 Feb 2027 estimated | NCT07762287 | Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants | Bayer | Menopause | Phase 1 | 100 |
| 28 Feb 2027 estimated | NCT07602530 | A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice | Astellas Pharma Europe Ltd. | Menopause | Observational | 238 |
| Mar 2027 estimated | NCT06543550 | Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis | Bio Meds Pharmaceutica Ltda | Endometriosis | Phase 4 | 70 |
| Mar 2027 estimated | NCT07386249 | Exploration of the Effect of a Wheat Polar Lipid Complex on Vaginal Dryness in Healthy Postmenopausal Women | Seppic | Menopause | N/A (non-drug) | 110 |
| 31 Mar 2027 estimated | NCT07755956 | Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis | Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. | Endometriosis | Phase 1 | 30 |
| Q2 2027 | ||||||
| 7 Apr 2027 estimated | NCT07548307 | Radicle Revive™: A Study Assessing the Impact of Health and Wellness Products on Menopausal-Related Health Issues Associated Health Outcomes and Related Health Outcomes | Radicle Science | Menopause | N/A (non-drug) | 990 |
| May 2027 estimated | NCT05739136 | MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy | Sumitomo Pharma Switzerland GmbH | Endometriosis | Observational | 530 |
| May 2027 estimated | NCT07663305 | Evaluation of a Mobile Menopause Application | Endo Health GmbH | Menopause | N/A (non-drug) | 426 |
| 31 May 2027 estimated | NCT07794150 | A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects | Corium Innovations, Inc. | Menopause | Phase 1 | 250 |
| Jun 2027 estimated | NCT07260669 | A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis | Gesynta Pharma AB | Endometriosis | Phase 2 | 213 |
| 15 Jun 2027 estimated | NCT07393295 | Efficacy and Tolerability of TENS in Endometriosis-related Pain | Monath Electronic | Endometriosis | N/A (non-drug) | 92 |
| Q3 2027 | ||||||
| Jul 2027 estimated | NCT04333576 | Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain | AbbVie | Endometriosis | Phase 3 | 800 |
| 31 Aug 2027 estimated | NCT07834463 | Randomized Evaluation of Natural Extract for Menopausal Wellness (RENEW) | India Glycols Ltd | Menopause | N/A (non-drug) | 100 |
| 15 Sep 2027 estimated | NCT07824648 | Thermoregulatory Physiology of Menopausal Hot Flashes | SRI International | Menopause | N/A (non-drug) | 40 |
Included: ClinicalTrials.gov records with an industry lead sponsor and a status of recruiting, not yet recruiting, active (not recruiting) or enrolling by invitation. Month-only dates are shown as the month. EU CTIS search results don't carry a primary completion date, so EU-only trials aren't listed here.
Free weekly digest
Get readout changes every Monday
When a sponsor moves a completion date, changes phase or stops a trial, it's in the digest, with registry links.
Your ticks help us prioritise what to build. They don't commit you to anything, and no payment is taken.
Want biotech news too? Closewire: nightly recap of what moved in Tech and Health stocks, plus a free Sunday weekly. Subscribe to Closewire →
Business research data, not medical advice. TrialsForHer summarises public registry records from ClinicalTrials.gov and the EU Clinical Trials Information System (CTIS) for professional and research use. Registry entries can be incomplete or out of date, and dates marked "est." are the sponsor's own estimates. Always check the official record. This isn't a way to enrol in a study; patients and carers should talk to their clinician or the study team listed on the registry.